RewiredBio

At RewiredBio, we're using artificial intelligence to design smart drugs with the aim of reducing off-target effects. We achieve this by combining proprietary techniques in synthetic biology and machine learning to gain finer control of protein folding. As a result, we are expanding the paradigms of drug design. Our first target is a pathway that is implicated in over 90% of Cancers. Stay tuned for our progress.